Skip to content

FP7H2020HORIZON

Genos Doo za Vjestacenje i Analizu

Country
HRCroatia
Defence projects
0
Projects, all programmes
16
As coordinator
0
EU contribution (CORDIS)
EUR 10,994,694
Active
2011 to 2025

Projects

16 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
GlycoBoostPrecision control of glycosylation to open a new era of therapeutic antibodiesHORIZON2025ParticipantEUR 792,278
AttractAdriaAttractive Research Ecosystem in the Adria Region in the Field of Personalised Preventive HealthcareHORIZON2025ParticipantEUR 401,500
EXPAND-EVEXPANDing the value of Extracellular Vesicles as carriers of biomarker and therapy in precision healhcareHORIZON2025ParticipantEUR 230,000
GlycanSwitchGlycans as Master Switches of B Cell Activity in AutoimmunityHORIZON2023ParticipantEUR 2,364,750
OMRPO-Glc-NAc modifications of RNA-binding proteinsHORIZON2023Associated partnerEUR 0
Back-UPPersonalised Prognostic Models to Improve Well-being and Return to Work After Neck and Low Back PainH20202018ParticipantEUR 759,850
IMforFUTUREInnovative training in methods for future dataH20202017ParticipantEUR 247,761
SYSCIDA Systems medicine approach to chronic inflammatory diseaseH20202017ParticipantEUR 886,743
GlySignExploitation of Glycosylation Signatures for Precision MedicineH20202016ParticipantEUR 495,522
GlyCoCanExploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therapeuticsH20202015ParticipantEUR 371,642
HTP-GLYCOMETMethods for high-throughput glycoproteomic analysisFP72013ParticipantEUR 560,257
PAIN-OMICSMulti-dimensional omics approach to stratification of patients with low back painFP72013ParticipantEUR 990,300
MIMOMICSMethods for Integrated analysis of Multiple Omics datasetsFP72012ParticipantEUR 289,350
IBD-BIOMDiagnostic and prognostic biomarkers for inflammatory bowel disease IBD-BIOMFP72012ParticipantEUR 988,360
HIGHGLYCANMethods for high-throughput (HTP) analysis of protein glycosylationFP72011ParticipantEUR 988,580
GLYCOBIOMTools for the Detection of Novel Glyco-biomarkersFP72011ParticipantEUR 627,802

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.